Dendrimer-like alpha-d-glucan nanoparticles activate dendritic cells and are effective vaccine adjuvants

Fangjia Lu, Alejandra Mencia, Lin Bi, Aaron Taylor, Yuan Yao, Harm HogenEsch

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

The use of nanoparticles for delivery of vaccine antigens and as vaccine adjuvants is appealing because their size allows efficient uptake by dendritic cells and their biological properties can be tailored to the desired function. Here, we report the effect of chemically modified phytoglycogen, a dendrimer-like α-d-glucan nanoparticle, on dendritic cells in vitro, and the utility of this type of nanoparticle as a vaccine adjuvant in vivo. The modified phytoglycogen nanoparticle, termed Nano-11, has a positive surface charge which enabled electrostatic adsorption of negatively charged protein antigens. The Nano-11-antigen complexes were efficiently phagocytized by dendritic cells. Nano-11 induced increased expression of costimulatory molecules and the secretion of IL-1β and IL-12p40 by dendritic cells. Intramuscular injection of Nano-11-antigen formulations induced a significantly enhanced immune response to two different protein antigens. Examination of the injection site revealed numerous monocytes and relatively few neutrophils at one day after injection. The inflammation had nearly completely disappeared by 2 weeks after injection. These studies indicate that Nano-11 is an effective vaccine delivery vehicle that significantly enhances the immune response. This type of plant based nanoparticle is considered highly cost-effective compared with fully synthetic nanoparticles and appears to have an excellent safety profile making them an attractive adjuvant candidate for prophylactic vaccines.

Original languageEnglish (US)
Article number7587
Pages (from-to)51-59
Number of pages9
JournalJournal of Controlled Release
Volume204
DOIs
StatePublished - Apr 28 2015
Externally publishedYes

Fingerprint

Dendrimers
Glucans
Nanoparticles
Dendritic Cells
Vaccines
Antigens
Injections
Interleukin-12 Subunit p40
Intramuscular Injections
Static Electricity
Interleukin-1
Adsorption
Monocytes
Proteins
Neutrophils
Inflammation
Safety
Costs and Cost Analysis

Keywords

  • Adjuvants
  • Dendritic cells
  • IL-1β
  • Inflammation
  • Nanoparticles
  • Vaccines

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Medicine(all)

Cite this

Dendrimer-like alpha-d-glucan nanoparticles activate dendritic cells and are effective vaccine adjuvants. / Lu, Fangjia; Mencia, Alejandra; Bi, Lin; Taylor, Aaron; Yao, Yuan; HogenEsch, Harm.

In: Journal of Controlled Release, Vol. 204, 7587, 28.04.2015, p. 51-59.

Research output: Contribution to journalArticle

Lu, Fangjia ; Mencia, Alejandra ; Bi, Lin ; Taylor, Aaron ; Yao, Yuan ; HogenEsch, Harm. / Dendrimer-like alpha-d-glucan nanoparticles activate dendritic cells and are effective vaccine adjuvants. In: Journal of Controlled Release. 2015 ; Vol. 204. pp. 51-59.
@article{52f7b52e26454cd39318ea63690e4212,
title = "Dendrimer-like alpha-d-glucan nanoparticles activate dendritic cells and are effective vaccine adjuvants",
abstract = "The use of nanoparticles for delivery of vaccine antigens and as vaccine adjuvants is appealing because their size allows efficient uptake by dendritic cells and their biological properties can be tailored to the desired function. Here, we report the effect of chemically modified phytoglycogen, a dendrimer-like α-d-glucan nanoparticle, on dendritic cells in vitro, and the utility of this type of nanoparticle as a vaccine adjuvant in vivo. The modified phytoglycogen nanoparticle, termed Nano-11, has a positive surface charge which enabled electrostatic adsorption of negatively charged protein antigens. The Nano-11-antigen complexes were efficiently phagocytized by dendritic cells. Nano-11 induced increased expression of costimulatory molecules and the secretion of IL-1β and IL-12p40 by dendritic cells. Intramuscular injection of Nano-11-antigen formulations induced a significantly enhanced immune response to two different protein antigens. Examination of the injection site revealed numerous monocytes and relatively few neutrophils at one day after injection. The inflammation had nearly completely disappeared by 2 weeks after injection. These studies indicate that Nano-11 is an effective vaccine delivery vehicle that significantly enhances the immune response. This type of plant based nanoparticle is considered highly cost-effective compared with fully synthetic nanoparticles and appears to have an excellent safety profile making them an attractive adjuvant candidate for prophylactic vaccines.",
keywords = "Adjuvants, Dendritic cells, IL-1β, Inflammation, Nanoparticles, Vaccines",
author = "Fangjia Lu and Alejandra Mencia and Lin Bi and Aaron Taylor and Yuan Yao and Harm HogenEsch",
year = "2015",
month = "4",
day = "28",
doi = "10.1016/j.jconrel.2015.03.002",
language = "English (US)",
volume = "204",
pages = "51--59",
journal = "Journal of Controlled Release",
issn = "0168-3659",
publisher = "Elsevier",

}

TY - JOUR

T1 - Dendrimer-like alpha-d-glucan nanoparticles activate dendritic cells and are effective vaccine adjuvants

AU - Lu, Fangjia

AU - Mencia, Alejandra

AU - Bi, Lin

AU - Taylor, Aaron

AU - Yao, Yuan

AU - HogenEsch, Harm

PY - 2015/4/28

Y1 - 2015/4/28

N2 - The use of nanoparticles for delivery of vaccine antigens and as vaccine adjuvants is appealing because their size allows efficient uptake by dendritic cells and their biological properties can be tailored to the desired function. Here, we report the effect of chemically modified phytoglycogen, a dendrimer-like α-d-glucan nanoparticle, on dendritic cells in vitro, and the utility of this type of nanoparticle as a vaccine adjuvant in vivo. The modified phytoglycogen nanoparticle, termed Nano-11, has a positive surface charge which enabled electrostatic adsorption of negatively charged protein antigens. The Nano-11-antigen complexes were efficiently phagocytized by dendritic cells. Nano-11 induced increased expression of costimulatory molecules and the secretion of IL-1β and IL-12p40 by dendritic cells. Intramuscular injection of Nano-11-antigen formulations induced a significantly enhanced immune response to two different protein antigens. Examination of the injection site revealed numerous monocytes and relatively few neutrophils at one day after injection. The inflammation had nearly completely disappeared by 2 weeks after injection. These studies indicate that Nano-11 is an effective vaccine delivery vehicle that significantly enhances the immune response. This type of plant based nanoparticle is considered highly cost-effective compared with fully synthetic nanoparticles and appears to have an excellent safety profile making them an attractive adjuvant candidate for prophylactic vaccines.

AB - The use of nanoparticles for delivery of vaccine antigens and as vaccine adjuvants is appealing because their size allows efficient uptake by dendritic cells and their biological properties can be tailored to the desired function. Here, we report the effect of chemically modified phytoglycogen, a dendrimer-like α-d-glucan nanoparticle, on dendritic cells in vitro, and the utility of this type of nanoparticle as a vaccine adjuvant in vivo. The modified phytoglycogen nanoparticle, termed Nano-11, has a positive surface charge which enabled electrostatic adsorption of negatively charged protein antigens. The Nano-11-antigen complexes were efficiently phagocytized by dendritic cells. Nano-11 induced increased expression of costimulatory molecules and the secretion of IL-1β and IL-12p40 by dendritic cells. Intramuscular injection of Nano-11-antigen formulations induced a significantly enhanced immune response to two different protein antigens. Examination of the injection site revealed numerous monocytes and relatively few neutrophils at one day after injection. The inflammation had nearly completely disappeared by 2 weeks after injection. These studies indicate that Nano-11 is an effective vaccine delivery vehicle that significantly enhances the immune response. This type of plant based nanoparticle is considered highly cost-effective compared with fully synthetic nanoparticles and appears to have an excellent safety profile making them an attractive adjuvant candidate for prophylactic vaccines.

KW - Adjuvants

KW - Dendritic cells

KW - IL-1β

KW - Inflammation

KW - Nanoparticles

KW - Vaccines

UR - http://www.scopus.com/inward/record.url?scp=84924426166&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84924426166&partnerID=8YFLogxK

U2 - 10.1016/j.jconrel.2015.03.002

DO - 10.1016/j.jconrel.2015.03.002

M3 - Article

VL - 204

SP - 51

EP - 59

JO - Journal of Controlled Release

JF - Journal of Controlled Release

SN - 0168-3659

M1 - 7587

ER -